Among them, IL-33 was considered a pro-cancer cytokine, since the activation pathway of IL-33/ST2 may promote metastases, as observed in some tumors, such as colorectal and ovarian cancer [19,20]. The gene discussed is IL1RL1; the disease is cancer.